GlaxoSmithKline Pharmaceuticals Limited
NSE: GLAXO · Healthcare
₹2,963.40
+31.70 (+1.08%)
Last close · 30 Aug 2026, 2:50 am IST
- Open
- ₹2,953.80
- Day high
- ₹3,010.00
- Day low
- ₹2,917.60
- Volume
- 1.74 L
- Prev close
- ₹2,931.70
HealthcareDrug Manufacturers - GeneralPart of:All NSE StocksNifty 500Nifty Midcap 150Nifty MidSmallcap 400
Price chart
Range
EMA
Also show
Fundamentals
Drug Manufacturers - General
Valuation
- Market Cap
- 42,594 Cr
- Price
- 2,514.30
- P/E (TTM)
- 41.15
- P/E (Fwd)
- 32.88
- P/B
- 18.79
- EV/EBITDA
- 31.00
- EV/Revenue
- 10.43
- PEG
- —
- Div Yield
- 2.27%
- 52W High
- 3,200.00
- 52W Low
- 2,088.10
- Beta
- 0.04
Profitability & income
- Revenue (TTM)
- 3,822 Cr
- Net Income (TTM)
- 1,036 Cr
- EBITDA
- 1,286 Cr
- Gross Margin
- 64.01%
- Op. Margin
- 34.42%
- Net Margin
- 27.11%
- ROE
- 49.11%
- ROA
- 18.50%
- EPS (TTM)
- 61.10
- EPS (Fwd)
- 76.48
Financial health
- Total Debt
- 33 Cr
- Total Cash
- 2,757 Cr
- Debt/Equity
- 1.47
- Current Ratio
- 2.03
- Quick Ratio
- 1.72
- Book Value
- 133.85
- Free Cash Flow
- 729 Cr
- Op. Cash Flow
- 903 Cr
Growth
- Revenue Growth
- 2.10%
- Earnings Growth
- 5.70%
- Earnings QoQ
- 5.70%
Quarterly results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 995 Cr | 278 Cr | 387 Cr | 338 Cr | 651 Cr | — | 33 Cr | 2,267 Cr |
| 2025-12-31 | 1,041 Cr | 296 Cr | 421 Cr | 351 Cr | 677 Cr | — | — | — |
| 2025-06-30 | 805 Cr | 205 Cr | 295 Cr | 236 Cr | 517 Cr | — | — | — |
| 2025-03-31 | 974 Cr | 263 Cr | 374 Cr | 318 Cr | 622 Cr | — | 10 Cr | 1,951 Cr |
| 2024-12-31 | 949 Cr | 230 Cr | 327 Cr | 273 Cr | 590 Cr | — | — | — |
Annual results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 3,808 Cr | 1,036 Cr | 1,475 Cr | 1,248 Cr | 2,386 Cr | — | — | — |
| 2025-03-31 | 3,726 Cr | 928 Cr | 1,328 Cr | 1,114 Cr | 2,253 Cr | — | — | — |
| 2024-03-31 | 3,442 Cr | 590 Cr | 888 Cr | 838 Cr | 2,022 Cr | — | — | — |
| 2023-03-31 | 3,226 Cr | 611 Cr | 904 Cr | 748 Cr | 1,868 Cr | — | — | — |
| 2022-03-31 | — | — | — | — | — | — | — | — |
Figures in ₹ crore unless stated. Ratios and margins are trailing twelve months where marked TTM.
Want charts and signals for GLAXO?
Sign in for candlestick charts with Supertrend, MACD and VWAP overlays, plus watchlists and email alerts.
Sign in